It contains semaglutide as an active ingredient and acts as a GLP-1 receptor agonist
The European Medicines Agency (EMA) European Public Assessment Report (EPAR) and the Medicines and Healthcare products Regulatory Authority (MHRA) approved Wegovy without specific warnings regarding male fertility, suggesting regulatory review of available data did not identify concerning signals
When it comes to cutting-edge weight loss and diabetes treatments, Semaglutide and Tirzepatide are two names youve probably heard a lot aboutand for good reason
Ryan, D.H., et al., Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
Semaglutide Semaglutide has been developed based on the vast body of research behind the development of liraglutide ( N -[8-(2-hydroxybenzoyl) aminocaprylate] or SNAC), which, when co-administered with semaglutide, was demonstrated to give therapeutic levels of the latter ( Both the subcutaneous and oral formulations of semaglutide have undergone extensive phase 3 clinical testing ( Table 1 )
